An Intelligent Clinical Decision Support System for Patient-Specific Predictions to Improve Cervical Intraepithelial Neoplasia Detection
Table 15
Definition of positivity of the medical tests involved in this study for performance evaluation purposes.
Medical tests
Definition of positivity
Pap test (cut-off ASCUS+)
ASCUS or worse
Pap test (cut-off LSIL+)
LSIL or worse
Pap test (cut-off HSIL+)
HSIL or worse
HPV DNA test
Existence of any HPV subtype found by the HPV DNA test
HR-HPV DNA
Existence of at least one of the high-risk subtypes found by the HPV DNA test
NASBA E6/E7 HPV mRNA test
Positive result of the E6/E7 HPV mRNA test (NASBA) for any of the HPV subtypes 16, 18, 31, 33, and 45
Flow cytometric E6/E7 HPV mRNA assay
Positive result of the identification of E6/E7 mRNA expression of high-risk HPV using flow cytometry technique (positive expression >1.5%)
p16
Positive result of the p16 immunocytochemical examination
Different positivity thresholds have been taken into consideration for Pap test and HPV DNA test. HR-HPV: high-risk human papillomavirus, ASCUS: atypical squamous cells of unknown significance, LSIL: low-grade intraepithelial lesion, and HSIL: high-grade squamous intraepithelial lesion.